You are here

Article info

Article menu
Download PDFPDF
Multiple sclerosis
Original research
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

Authors

  • Serena Ruggieri Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy PubMed articlesGoogle scholar articles
  • Luca Prosperini Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy PubMed articlesGoogle scholar articles
  • Sarmad Al-Araji Department of Neuroinflammation, Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK PubMed articlesGoogle scholar articles
  • Pietro Osvaldo Annovazzi Neuroimmunology Unit-Multiple Sclerosis Center, Hospital of Gallarate, ASST della Valle Olona, Gallarate, Italy PubMed articlesGoogle scholar articles
  • Alvino Bisecco Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy PubMed articlesGoogle scholar articles
  • Olga Ciccarelli Department of Neuroinflammation, Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK National Institute for Health Research Biomedical Research Centre, University College London Hospitals, London, UK PubMed articlesGoogle scholar articles
  • Nicola De Stefano Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy PubMed articlesGoogle scholar articles
  • Massimo Filippi Neurology Unit and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, Milan, Italy PubMed articlesGoogle scholar articles
  • Vinzenz Fleischer Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University, Mainz, Germany PubMed articlesGoogle scholar articles
  • Nikos Evangelou Mental Health & Clinical Neuroscience Unit, University of Nottingham, Nottingham, UK Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK PubMed articlesGoogle scholar articles
  • Christian Enzinger Department of Neurology, Medical University of Graz, Graz, Austria Department of Radiology (Division of Neuroradiology, Vascular and Interventional Radiology), Medical University of Graz, Graz, Austria PubMed articlesGoogle scholar articles
  • Antonio Gallo Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy PubMed articlesGoogle scholar articles
  • Afagh Garjani Mental Health & Clinical Neuroscience Unit, University of Nottingham, Nottingham, UK Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK PubMed articlesGoogle scholar articles
  • Sergiu Groppa Department of Neurology and Neuroimaging Center (NIC) of the Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University, Mainz, Germany PubMed articlesGoogle scholar articles
  • Shalom Haggiag Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy PubMed articlesGoogle scholar articles
  • Michael Khalil Department of Neurology, Medical University of Graz, Graz, Austria PubMed articlesGoogle scholar articles
  • Matteo Lucchini Multiple Sclerosis Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy Centro di ricerca Sclerosi Multipla (CERSM), Università Cattolica del Sacro Cuore, Rome, Italy PubMed articlesGoogle scholar articles
  • Massimiliano Mirabella Multiple Sclerosis Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy Centro di ricerca Sclerosi Multipla (CERSM), Università Cattolica del Sacro Cuore, Rome, Italy PubMed articlesGoogle scholar articles
  • Xavier Montalban Centre d'Esclerosi Multiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Carlo Pozzilli Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy PubMed articlesGoogle scholar articles
  • Paolo Preziosa Neurology Unit and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, Milan, Italy PubMed articlesGoogle scholar articles
  • Jordi Río Centre d'Esclerosi Multiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Maria A Rocca Neurology Unit and Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, Milan, Italy PubMed articlesGoogle scholar articles
  • Alex Rovira Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Maria L Stromillo Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy PubMed articlesGoogle scholar articles
  • Mauro Zaffaroni Neuroimmunology Unit-Multiple Sclerosis Center, Hospital of Gallarate, ASST della Valle Olona, Gallarate, Italy PubMed articlesGoogle scholar articles
  • Carla Tortorella Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy PubMed articlesGoogle scholar articles
  • Claudio Gasperini Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy PubMed articlesGoogle scholar articles
  • MAGNIMS Study Group
    Google scholar articles
  1. Correspondence to Dr Claudio Gasperini, Department of Neurosciences, San Camillo Forlanini Hospital, Rome 00152, Italy; c.gasperini{at}libero.it
View Full Text

Citation

Ruggieri S, Prosperini L, Al-Araji S MAGNIMS Study Group, et al
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Journal of Neurology, Neurosurgery & Psychiatry 2024;95:142-150.

Publication history

  • Received May 26, 2023
  • Accepted August 9, 2023
  • First published September 29, 2023.
Online issue publication 
January 11, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.